Royal Bank of Canada’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-6,597
| Closed | -$923K | – | 7370 |
|
|
2018
Q4 | $923K | Sell |
6,597
-14,578
| -69% | -$2.21M | ﹤0.01% | 3228 |
|
|
2018
Q3 | $3.62M | Buy |
21,175
+12,104
| +133% | +$2.03M | ﹤0.01% | 2369 |
|
|
2018
Q2 | $1.57M | Buy |
9,071
+8,226
| +973% | +$1.24M | ﹤0.01% | 2903 |
|
|
2018
Q1 | $97K | Buy |
845
+619
| +274% | +$65.8K | ﹤0.01% | 4718 |
|
|
2017
Q4 | $19K | Sell |
226
-44,455
| -99% | -$3.71M | ﹤0.01% | 5626 |
|
|
2017
Q3 | $4.12M | Buy |
44,681
+44,645
| +124,014% | +$3.47M | ﹤0.01% | 2132 |
|
|
2017
Q2 | $3K | Sell |
36
-417
| -92% | -$23.1K | ﹤0.01% | 6226 |
|
|
2017
Q1 | $19K | Buy |
453
+96
| +27% | +$3.95K | ﹤0.01% | 5666 |
|
|
2016
Q4 | $12K | Buy |
357
+355
| +17,750% | +$9.1K | ﹤0.01% | 6028 |
|
|
2016
Q3 | $0 | Buy |
+2
| New | +$52 | ﹤0.01% | 6700 |
|
|
2015
Q4 | – | Sell |
-364
| Closed | -$6K | – | 6981 |
|
|
2015
Q3 | $6K | Sell |
364
-91
| -20% | -$1.78K | ﹤0.01% | 6120 |
|
|
2015
Q2 | $8K | Buy |
455
+449
| +7,483% | +$6.14K | ﹤0.01% | 6150 |
|
|
2015
Q1 | $0 | Buy |
+6
| New | +$75 | ﹤0.01% | 6557 |
|
Other funds holding LOXO
Royal Bank of Canada's LOXO Position: Q1 2019 in Review
Royal Bank of Canada sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 6,597 shares — an estimated $923K sold.
Royal Bank of Canada first reported a position in LOXO in Q1 2015 and held it in 13 quarters. The position peaked at $4.12M in Q3 2017. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- Royal Bank of Canada reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- Royal Bank of Canada sold 6,597 Loxo Oncology, Inc shares in Q1 2019, an estimated $923K.
- Royal Bank of Canada first reported a position in Loxo Oncology, Inc in Q1 2015 and held it in 13 quarters.
- Royal Bank of Canada's Loxo Oncology, Inc position peaked at $4.12M in Q3 2017.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on Royal Bank of Canada's 13F filing for Q1 2019, filed 15 May 2019.